Snapshot from Jul 07, 2026 at 01:18 UTC. For live data and tracking: View Live
Company

Disc Medicine

Tracked across 3 events · 32 articles · First seen Apr 07, 2026 · Last active Jun 12, 2026

Sentiment
-35
Attention
4
Events
3
Relationships
8
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
2 -50
Regulatory
Impact: Disc Medicine, Inc. received a Complete Response Letter from the United States — Food and Drug Administration regarding its bitopertin program, leading to a 22% stock price drop and subsequent securities claims investigation.
May 01, 2026 · 6 articles
4 -56
Regulatory
Impact: Disc Medicine received a Complete Response Letter from the United States — Food and Drug Administration for its bitopertin program, leading to a significant drop in its stock price and a securities investigation.
Apr 29, 2026 · 20 articles
2 0
Regulatory
Apr 07, 2026 · 6 articles
Lawrence Rosen Disc Medicine
Lawrence Rosen Disc Medicine
Philip Kim Disc Medicine
Philip Kim Disc Medicine
Rosen Law Firm Disc Medicine
Rosen Law Firm Disc Medicine
ERGEN INTELLIGENCE
Track Disc Medicine live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.